Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07605884

Denys-Drash Syndrome and Risk of Post-transplant Lymphoproliferative Disorder

Sponsor: Assistance Publique - Hôpitaux de Paris

View on ClinicalTrials.gov

Summary

Denys-Drash syndrome is a rare genetic disorder of childhood characterized by nephrotic syndrome, nephroblastomas, and genital developmental abnormalities. These children present with rapidly progressive renal failure, leading to kidney transplantation at a median age of 3.6 years. In a study of the French cohort of patients with Denys-Drash syndrome, a high risk of lymphoproliferative syndrome was observed (20%). This frequency is significantly higher than in the general transplant population (4%). The aim of the study is to evaluate the risk of post-transplant lymphoproliferative disorder following kidney transplantation in patients with Denys-Drash syndrome compared to patients with kidney transplant patients without Denys-Drash syndrome.

Official title: Post-transplant Lymphoproliferative Disorder Following Kidney Transplantation in Denys-Drash Syndrome: a Case-control Study

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

108

Start Date

2026-06

Completion Date

2027-06

Last Updated

2026-05-26

Healthy Volunteers

No

Interventions

OTHER

Collection of data from the patient's medical file

Collection of data from the patient's medical file. The data will be collected until 2024.

Locations (7)

Hôpital Femme Mère Enfant, Hospices Civils de Lyon

Bron, France

CHU de Lille

Lille, France

CHU Montpellier

Montpellier, France

CHU de Nancy - Hôpitaux de Brabois

Nancy, France

Hôpital enfants et adolescents, CHU Nantes

Nantes, France

Hôpital Necker-Enfants Malades

Paris, France

Hôpital Robert Debré

Paris, France